Abstract
Background
Ureaplasma species are common pathogens of the urogenital tract and can cause a range of diseases. Unfortunately, there is still a scarcity of large-scale and cross-sectional studies on the prevalence of Ureaplasma species in China to clarify their epidemic patterns.
Methods
This study retrospectively analyzed the data of 18667 patients who visited Peking Union Medical College Hospital for showing various symptoms of (suspected) Ureaplasma species infection during the period 2013–2022. The overall prevalence of Ureaplasma species was calculated, and subgroup analyses were conducted in view of gender, age, specimen types, and diagnosis in every year within the period studied. Furthermore, previous literature that reported on the prevalence of Ureaplasma species in various regions of China was searched and summarized.
Results
The overall positive rate of Ureaplasma species in this study reached 42.1% (7861/18667). Specifically, the prevalence of Ureaplasma species was significantly higher in female patients, while the highest detection rate was found in the 21–50 age group. From 2013 to 2022, there were no significant differences in positive rates of Ureaplasma species among years. However, the detection rate of Ureaplasma species was decreased in COVID-19 period (2020–2022) compared to pre-COVID-19 period (2017–2019). In view of the distribution of patients, outpatients predominated, but the detection rate was lower than inpatients. Urine was the most common specimen type, while cervical swabs had the highest detection rate of Ureaplasma species. When grouped by diagnosis, the highest positive rate of Ureaplasma species was seen in patients with adverse pregnancy outcomes and the lowest rate in patients with prostate disease. The previous literature, although heterogeneous, collectively suggested a high prevalence of Ureaplasma species in China.
Conclusions
Our study has shown that Ureaplasma species have reached a significant prevalence in China and demands adequate attention.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Kokkayil P, Dhawan B (2015) Ureaplasma: current perspectives. Indian J Med Microbiol 33(2):205–214
Robertson JA, Stemke GW, Davis JW, Harasawa R, Thirkell D, Kong F, Shepard MC, Ford DK (2002) Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard et al. 1974) Robertson et al. 2001. Int J Syst Evol Microbiol 52(Pt 2):587–597
Shepard MC (1954) The recovery of pleuropneumonia-like organisms from Negro men with and without nongonococcal urethritis. Am J Syph Gonorrhea Vener Dis 38(2):113–124
Shepard MC, Lunceford CD (1967) Occurrence of urease in T strains of Mycoplasma. J Bacteriol 93(5):1513–1520
Hudson MM, Talbot MD (1997) Ureaplasma urealyticum. Int J STD AIDS 8(9):546–551
Couldwell DL, Gidding HF, Freedman EV, McKechnie ML, Biggs K, Sintchenko V, Gilbert GL (2010) Ureaplasma urealyticum is significantly associated with non-gonococcal urethritis in heterosexual Sydney men. Int J STD AIDS 21(5):337–341
Perni SC, Vardhana S, Korneeva I, Tuttle SL, Paraskevas LR, Chasen ST, Kalish RB, Witkin SS (2004) Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: association with amniotic fluid cytokine levels and pregnancy outcome. Am J Obstet Gynecol 191(4):1382–1386
Huang C, Zhu HL, Xu KR, Wang SY, Fan LQ, Zhu WB (2015) Mycoplasma and ureaplasma infection and male infertility: a systematic review and meta-analysis. Andrology 3(5):809–816
Liu L, Cao G, Zhao Z, Zhao F, Huang Y (2014) High bacterial loads of Ureaplasma may be associated with non-specific cervicitis. Scand J Infect Dis 46(9):637–641
Capoccia R, Greub G, Baud D (2013) Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Curr Opin Infect Dis 26(3):231–240
Dewan B, Sharma M, Nayak N, Sharma SK (1997) Upper urinary tract stones & Ureaplasma urealyticum. Indian J Med Res 105:15–21
Ghosh A, Rawre J, Khanna N, Dhawan B (2013) Co-infections with Ureaplasma parvum, Mycoplasma hominis and Chlamydia trachomatis in a human immunodeficiency virus positive woman with vaginal discharge. Indian J Med Microbiol 31(2):190–192
Dando SJ, Nitsos I, Kallapur SG, Newnham JP, Polglase GR, Pillow JJ, Jobe AH, Timms P, Knox CL (2012) The role of the multiple banded antigen of Ureaplasma parvum in intra-amniotic infection: major virulence factor or decoy? PLoS One 7(1):e29856
De Silva NS, Quinn PA (1986) Endogenous activity of phospholipases A and C in Ureaplasma urealyticum. J Clin Microbiol 23(2):354–359
Waites KB, Katz B, Schelonka RL (2005) Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev 18(4):757–789
Pandelidis K, McCarthy A, Chesko KL, Viscardi RM (2013) Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates. Pediatr Infect Dis J 32(4):394–398
Lukic A, Canzio C, Patella A, Giovagnoli M, Cipriani P, Frega A, Moscarini M (2006) Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: the role of Ureaplasma urealyticum. Anticancer Res 26(6c):4843–4849
Moridi K, Hemmaty M, Azimian A, Fallah MH, Khaneghahi Abyaneh H, Ghazvini K (2020) Epidemiology of genital infections caused by Mycoplasma hominis, M. genitalium and Ureaplasma urealyticum in Iran; a systematic review and meta-analysis study (2000-2019). BMC Public Health 20(1):1020
Zhu C, Liu J, Ling Y, Dong C, Wu T, Yu X, Hou Y, Dong L, Cheng X (2012) Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Chinese women with genital infectious diseases. Indian J Dermatol Venereol Leprol 78(3):406–407
Ye G, Jiang Z, Wang M, Huang J, Jin G, Lu S (2014) The resistance analysis of Ureaplasma urealyticum and Mycoplasma hominis in female reproductive tract specimens. Cell Biochem Biophys 68(1):207–210
Huang C, Long X, Jing S, Fan L, Xu K, Wang S, Zhu W (2016) Ureaplasma urealyticum and Mycoplasma hominis infections and semen quality in 19,098 infertile men in China. World J Urol 34(7):1039–1044
Chen LS, Wu JR, Wang B, Yang T, Yuan R, Zhao YY, Xu JS, Guo HX, Huan XP (2015) Epidemiology of Mycoplasma acquisition in male HIV-1 infected patients: a multistage cross-sectional survey in Jiangsu, China. Epidemiol Infect 143(15):3327–3334
Wang QY, Li RH, Zheng LQ, Shang XH (2016) Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in female outpatients, 2009-2013. J Microbiol Immunol Infect 49(3):359–362
Zhu X, Li M, Cao H, Yang X, Zhang C (2016) Epidemiology of Ureaplasma urealyticum and Mycoplasma hominis in the semen of male outpatients with reproductive disorders. Exp Ther Med 12(2):1165–1170
Zeng XY, Xin N, Tong XN, Wang JY, Liu ZW (2016) Prevalence and antibiotic susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Xi'an, China. Eur J Clin Microbiol Infect Dis 35(12):1941–1947
Xu WH, Chen JJ, Sun Q, Wang LP, Jia YF, Xuan BB, Xu B, Sheng HM (2018) Chlamydia trachomatis, Ureaplasma urealyticum and Neisseria gonorrhoeae among Chinese women with urinary tract infections in Shanghai: a community-based cross-sectional study. J Obstet Gynaecol Res 44(3):495–502
Qing L, Song QX, Feng JL, Li HY, Liu G, Jiang HH (2017) Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Ureaplasma urealyticum infections using a novel isothermal simultaneous RNA amplification testing method in infertile males. Ann Clin Microbiol Antimicrob 16(1):45
Cai S, Pan J, Duan D, Yu C, Yang Z, Zou J (2020) Prevalence of Ureaplasma urealyticum, Chlamydia trachomatis, and Neisseria gonorrhoeae in gynecological outpatients, Taizhou, China. J Clin Lab Anal 34(2):e23072
Gu X, Liu S, Guo X, Weng R, Zhong Z (2020) Epidemiological investigation and antimicrobial susceptibility analysis of mycoplasma in patients with genital manifestations. J Clin Lab Anal 34(4):e23118
Zheng WW, Zhang WJ, Cui D, Nie ZC, Ding BS, Cheng JH, Mei CZ (2020) Examination of Ureaplasma urealyticum and Mycoplasma hominis in 4082 Chinese patients. Braz J Med Biol Res 54(2):e10099
Shao L, Wu X, Gao S, Liu L, Zhang Y, Zhao H (2021) Epidemiological investigation and antimicrobial susceptibility analysis of Ureaplasma and Mycoplasma hominis in a teaching hospital in Shenyang, China. J Infect Chemother 27(8):1212–1216
Zhang W, Li L, Zhang X, Fang H, Chen H, Rong C (2021) Infection prevalence and antibiotic resistance levels in Ureaplasma urealyticum and Mycoplasma hominis in gynecological outpatients of a tertiary hospital in China from 2015 to 2018. Can J Infect Dis Med Microbiol 2021:8842267
Luo R, Xun K, Zuo L, Sha F, Chen Y, Yu N, Jin D, Xie Y, He M, Liu F (2022) Prevalence and antimicrobial resistance of Ureaplasma urealyticum and Mycoplasma hominis in patients with genital tract infection in Jiangsu. China. Clin Lab 68(6):1151–1158
Liu T, Lai SY, Zhou W, Liu YL, Chen SS, Jiang YM (2022) Analysis of Ureaplasma urealyticum, Chlamydia trachomatis, Mycoplasma genitalium and Neisseria gonorrhoeae infections among obstetrics and gynecological outpatients in southwest China: a retrospective study. BMC Infect Dis 22(1):283
Lu Z, Zhao P, Lu H, Xiao M (2023) Analyses of human papillomavirus, Chlamydia trachomatis, Ureaplasma urealyticum, Neisseria gonorrhoeae, and co-infections in a gynecology outpatient clinic in Haikou area, China. BMC Womens Health 23(1):117
Liang YY, Zhai HY, Li ZJ, Jin X, Chen Y, Chen SP (2018) Prevalence of Ureaplasma urealyticum, Chlamydia trachomatis, Neisseria gonorrhoeae and herpes simplex virus in Beijing, China. Epidemiol Infect 147:e59
Horner P, Donders G, Cusini M, Gomberg M, Jensen JS, Unemo M (2018) Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? - a position statement from the European STI Guidelines Editorial Board. J Eur Acad Dermatol Venereol 32(11):1845–1851
Tadera K, Kitagawa H, Kitano H, Hara T, Kashiyama S, Nomura T, Omori K, Shigemoto N, Yokozaki M, Ohge H (2023) Prevalence of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum detection in urine and respiratory tract samples in Hiroshima, Japan. Heliyon 9(3):e14543
Glaser K, Silwedel C, Waaga-Gasser AM, Henrich B, Fehrholz M, Claus H, Speer CP (2018) Ureaplasma isolates differentially modulate growth factors and cell adhesion molecules in human neonatal and adult monocytes. Cytokine 105:45–48
Zhu GX, Lu C, Chen CJ, Feng PY, Ma H, Lu RB, Yuan YL (2011) Pathogenicity of Ureaplasma urealyticum and Ureaplasma parvum in the lower genital tract of female BALB/c mice. Can J Microbiol 57(12):987–992
Sharma A, Ahmad Farouk I, Lal SK (2021) COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention. Viruses 13(2):202
Pan A, Liu L, Wang C, Guo H, Hao X, Wang Q, Huang J, He N, Yu H, Lin X, Wei S, Wu T (2020) Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China. Jama 323(19):1915–1923
Knox CL, Cave DG, Farrell DJ, Eastment HT, Timms P (1997) The role of Ureaplasma urealyticum in adverse pregnancy outcome. Aust N Z J Obstet Gynaecol 37(1):45–51
Pavlidis I, Spiller OB, Sammut Demarco G, MacPherson H, Howie SEM, Norman JE, Stock SJ (2020) Cervical epithelial damage promotes Ureaplasma parvum ascending infection, intrauterine inflammation and preterm birth induction in mice. Nat Commun 11(1):199
Viscardi RM (2014) Ureaplasma species: role in neonatal morbidities and outcomes. Arch Dis Child Fetal Neonatal Ed 99(1):F87–F92
Funding
This work was supported by the National Key Research and Development Program of China (2022YFC2406500) and the Beijing Key Clinical Specialty for Laboratory Medicine Excellent Project (No. ZK201000).
Author information
Authors and Affiliations
Contributions
ZW and YD conceptualized and designed this study; ZW, YC, ZY, JY, and LK collected data; ZW and MX analyzed data and prepared tables and figures; ZW, HZ, GL, and RL performed the literature search and analysis; ZW drafted the manuscript; YD critically revised the manuscript. All authors read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study was performed in compliance with Declaration of Helsinki and approved by the Ethics Committee of Peking Union Medical College Hospital (No. K4146).
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 16 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wang, Z., Xia, M., Chen, Y. et al. Prevalence of Ureaplasma species among patients at a tertiary hospital in China: a 10-year retrospective study from 2013 to 2022. Eur J Clin Microbiol Infect Dis 42, 1425–1437 (2023). https://doi.org/10.1007/s10096-023-04678-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-023-04678-7